Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe study record’s update timeline now lists November 10 and November 12, 2026, replacing November 4 and November 5, 2026.SummaryDifference0.1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the metastatic-cancer TIL immunotherapy study is now displayed, with details on eligibility, treatment arms, outcomes, contacts, publications, and data sharing.SummaryDifference81%

- Check14 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces an NIH-wide transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the study record page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision marker changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.